SharkNinja (SN) Liabilities — Quarterly & Annual

Screener

Liabilities at other companies

Cal-Maine FoodsCALM

$467.04M-9.9%

NewAmsterdam Pharma CompanyNAMS

$73.03M+99.5%

SharkNinjaSN

$2.75B—

United TherapeuticsUTHR

$819.8M+11.6%

Recursion Pharmaceuticals, Inc.RXRX

$297.67M-22.3%

Owens CorningOC

$8.92B-3.9%

Other financials

Income statement

Revenue$1.8B+22.2%

Gross profit$860.3M+21.5%

Operating income$179.4M+6.4%

Net income$129.8M-7.0%

EPS (diluted)$0.92-6.1%

Balance sheet

Cash & equivalents$779.8M+314%

Total debt$913.0M—

Total equity$2.8B+28.8%

Total assets$5.6B—

Cash flow

Operating cash flow$431.8M+4,854%

CapEx$49.1M+79.1%

Free cash flow$382.6M+1,148%

Valuation

Market cap$25.77B+60.1%

Enterprise value$25.91B—

P/E50.7×+21.3×

P/S4.4×+2.6×

Profitability

Gross margin48.6%+1.9pp

Operating margin11.7%+1.3pp

Net margin8.8%+2.6pp

FCF margin0.6%-4.2pp

Returns & leverage

Return on equity25.7%+15.6pp

Debt / equity0.3×—

Current ratio2.1×—

Where this comes from

Reported directly by SharkNinja in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: SharkNinja’s 10-Q, filed August 5, 2026. Open the filing →

Filed: Aug 5, 2026, 7:01 AM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001957132-26-000048

FAQ

What is SharkNinja's liabilities?: SharkNinja (SN) reported liabilities of $2.75B in Q2 2026.
What does liabilities mean?: Liabilities as reported by SharkNinja, Inc..

Ask your AI about SharkNinja's liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk